137 related articles for article (PubMed ID: 26342564)
1. Plasma mid-regional pro-adrenomedullin levels are inversely associated with anxiety but unrelated to depression: Results from the observational DIAST-CHF study in patients with cardiovascular risk factors.
Meyer T; Herrmann-Lingen C; Chavanon ML; Pieske B; Wachter R; Edelmann F
Psychoneuroendocrinology; 2015 Dec; 62():227-32. PubMed ID: 26342564
[TBL] [Abstract][Full Text] [Related]
2. Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.
Meyer T; Herrrmann-Lingen C; Chavanon ML; Nolte K; Pasedach CA; Binder L; Pieske B; Hasenfuss G; Wachter R; Edelmann F
Clin Res Cardiol; 2015 Jul; 104(7):574-81. PubMed ID: 25665711
[TBL] [Abstract][Full Text] [Related]
3. Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.
Eggers KM; Venge P; Lindahl B; Lind L
Int J Cardiol; 2013 Oct; 168(4):3537-42. PubMed ID: 23722054
[TBL] [Abstract][Full Text] [Related]
4. Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.
Haaf P; Twerenbold R; Reichlin T; Faoro J; Reiter M; Meune C; Steuer S; Bassetti S; Ziller R; Balmelli C; Campodarve I; Zellweger C; Kilchenmann A; Irfan A; Papassotiriou J; Drexler B; Mueller C
Int J Cardiol; 2013 Sep; 168(2):1048-55. PubMed ID: 23199555
[TBL] [Abstract][Full Text] [Related]
5. Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.
Brouwers FP; de Boer RA; van der Harst P; Struck J; de Jong PE; de Zeeuw D; Gans RO; Gansevoort RT; Hillege HL; van Gilst WH; Bakker SJ
Heart; 2012 Sep; 98(18):1348-53. PubMed ID: 22821276
[TBL] [Abstract][Full Text] [Related]
6. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
Neumann JT; Tzikas S; Funke-Kaiser A; Wilde S; Appelbaum S; Keller T; Ojeda-Echevarria F; Zeller T; Zwiener I; Sinning CR; Jagodzinski A; Schnabel RB; Lackner KJ; Münzel T; Blankenberg S; Wild PS; Sydow K
Atherosclerosis; 2013 Jun; 228(2):451-9. PubMed ID: 23562132
[TBL] [Abstract][Full Text] [Related]
7. Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study.
Sadlonova M; Meyer T; Binder L; Wachter R; Edelmann F; Herrmann-Lingen C
Psychoneuroendocrinology; 2019 Mar; 101():272-277. PubMed ID: 30594111
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
9. Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study.
Meyer T; Chavanon ML; Herrrmann-Lingen C; Roggenthien M; Nolte K; Pieske B; Wachter R; Edelmann F
PLoS One; 2015; 10(8):e0136739. PubMed ID: 26322793
[TBL] [Abstract][Full Text] [Related]
10. Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.
von Haehling S; Filippatos GS; Papassotiriou J; Cicoira M; Jankowska EA; Doehner W; Rozentryt P; Vassanelli C; Struck J; Banasiak W; Ponikowski P; Kremastinos D; Bergmann A; Morgenthaler NG; Anker SD
Eur J Heart Fail; 2010 May; 12(5):484-91. PubMed ID: 20215339
[TBL] [Abstract][Full Text] [Related]
11. Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest.
Zelniker TA; Schwall D; Hamidi F; Steinbach S; Scheller P; Spaich S; Michels G; Giannitsis E; Katus HA; Frey N; Preusch MR
Eur Heart J Acute Cardiovasc Care; 2023 Jun; 12(6):364-371. PubMed ID: 36943296
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction.
Elmas E; Lang S; Dempfle CE; Kälsch T; Papassotiriou J; Morgenthaler NG; Borggrefe M; Brueckmann M
Int J Cardiol; 2008 Aug; 128(1):107-11. PubMed ID: 17698224
[TBL] [Abstract][Full Text] [Related]
13. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts?
Kaiser R; Abdul-Khaliq H; Wilkens H; Herrmann E; Raedle-Hurst TM
Eur J Heart Fail; 2014 Oct; 16(10):1082-8. PubMed ID: 25201135
[TBL] [Abstract][Full Text] [Related]
14. High plasma mid-regional pro-adrenomedullin levels in children with severe dengue virus infections.
Michels M; Djamiatun K; Faradz SM; Koenders MM; de Mast Q; van der Ven AJ
J Clin Virol; 2011 Jan; 50(1):8-12. PubMed ID: 20952250
[TBL] [Abstract][Full Text] [Related]
15. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
[TBL] [Abstract][Full Text] [Related]
16. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
[TBL] [Abstract][Full Text] [Related]
17. Association between Mid-Regional Proadrenomedullin Levels and Progression of Deep White Matter Lesions in the Brain Accompanying Cognitive Decline.
Kuriyama N; Ihara M; Mizuno T; Ozaki E; Matsui D; Watanabe I; Koyama T; Kondo M; Tokuda T; Tamura A; Yamada K; Akazawa K; Takeda K; Takada A; Mizuno S; Nakagawa M; Watanabe Y
J Alzheimers Dis; 2017; 56(4):1253-1262. PubMed ID: 28234256
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.
Behnes M; Papassotiriou J; Walter T; Fiedler E; Sauer T; Lang S; Elmas E; Hoffmann U; Borggrefe M; Brueckmann M
Clin Chem Lab Med; 2008; 46(2):204-11. PubMed ID: 18076360
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
Funke-Kaiser A; Havulinna AS; Zeller T; Appelbaum S; Jousilahti P; Vartiainen E; Blankenberg S; Sydow K; Salomaa V
Ann Med; 2014 May; 46(3):155-62. PubMed ID: 24506434
[TBL] [Abstract][Full Text] [Related]
20. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.
Christ-Crain M; Morgenthaler NG; Struck J; Harbarth S; Bergmann A; Müller B
Crit Care; 2005; 9(6):R816-24. PubMed ID: 16356231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
